References
Kyle RA, Maldonado JE, Bayrd ED. Plasma cell leukemia: report on 17 cases. Arch Intern Med. 1974;133:813–8.
Lorsbach RB, Hsi ED, Dogan A, et al. Plasma cell myeloma and related neoplasms. Am J Clin Pathol. 2011;136:168–82.
Tiedemann RE, Gonzalez-Paz N, Kyle RA, et al. Genetic aberrations and survival in plasma cell leukemia. Leukemia. 2008;22:1044–52.
Cocciolillo F, Treglia G, Villani MF, et al. Atypical presentation of plasma cell leukemia secondary to multiple myeloma detected by F-18 FDG PET/CT. Clin Nucl Med. 2011;36:e220–3.
Yokoyama I, Inoue Y, Moritan T, et al. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET. J Nucl Med. 2003;44:1592–8.
Kelley DE, Williams KV, Price JC. Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET. Am J Physiol Endocrinol Metab. 1999;277:E361–9.
Tashiro M, Fujimoto T, Itoh M, et al. 18F-FDG PET imaging of muscle activity in runners. J Nucl Med. 1999;40:70–6.
Aydin A, Hickeson M, Yu JQ, et al. Demonstration of excessive metabolic activity of thoracic and abdominal muscles on FDG-PET in patients with chronic obstructive pulmonary disease. Clin Nucl Med. 2005;30:159–64.
Jackson RS, Schlarman TC, Hubble WL, et al. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET. J Nucl Med Technol. 2006;34:29–33.
Funding
None
Conflict of interest
The Authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Carmelo Caldarella and Giorgio Treglia equally contributed to this paper, and share first authorship.
Rights and permissions
About this article
Cite this article
Caldarella, C., Treglia, G., Leccisotti, L. et al. Coexistence of Physiologic and Abnormal Muscle Uptake of Fluorine-18-Fluorodeoxyglucose in a Patient with Plasma Cell Leukemia. Nucl Med Mol Imaging 46, 311–313 (2012). https://doi.org/10.1007/s13139-012-0163-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-012-0163-7